News | Science Selection Issue 12 | December 2014 | Vol. 122
PFOA and High Cholesterol: Basis for the Finding of a Probable Link
Kellyn S. Betts writes about environmental contaminants, hazards, and technology for solving environmental problems for publications including EHP and Environmental Science & Technology.
Citation: Betts KS. 2014. PFOA and high cholesterol: basis for the finding of a probable link. Environ Health Perspect 122:A338; http://dx.doi.org/10.1289/ehp.122-A338
Published: 1 December 2014
Related EHP Article
The C8 Science Panel was created as part of a class action settlement to study the relationship between perfluorooctanoic acid (PFOA) and disease in the community surrounding DuPont’s Washington Works facility in West Virginia.1 The panel of three epidemiologists has judged there to be a “probable link”2 between exposure to PFOA and several health conditions: kidney and testicular cancers, pregnancy-induced hypertension, thyroid disease, ulcerative colitis, and high cholesterol.3 In this issue of EHP, panelist Kyle Steenland and colleague Andrea Winquist, both of Emory University, report part of the basis for the probable link with high cholesterol.4
Nearly all U.S. adults sampled in the nationally representative U.S. National Health and Nutrition Examination Survey (NHANES) between 1999 and 2008 had detectable levels of PFOA in their blood.5 The residents around the Washington Works facility, which produced PFOA for decades starting in the early 1950s, received unusually high exposures through contaminated drinking water; some also worked at the plant.4 At least 14 human studies, most of them cross-sectional in design, have linked PFOA exposure with heart disease risk factors (including higher levels of uric acid and homocysteine in serum) and higher serum cholesterol.4
After assessing the existing scientific evidence and estimating community and worker exposures to PFOA, the C8 Science Panel concluded there is a “probable link” between PFOA exposure and high cholesterol among the population around DuPont’s Washington Works facility.
The C8 Science Panel used several models to analyze data collected from 3,713 workers and 28,541 other members of the community.6 A fate and transport model with data on the plant’s PFOA emissions was used to estimate annual exposure of the community members through local air, surface water, and groundwater.7 To estimate yearly PFOA intakes, the panel combined modeled water concentration calculations with information about residential history, drinking water sources, and water consumption rates.8 They then used a pharmacokinetic model to approximate PFOA serum concentrations for community members. For workers, an occupational model generated job- and department-specific PFOA serum concentration estimates.9 For people who both lived in the community and worked at the plant, the analysis used whichever PFOA estimate was higher for any given year.
The panel analyzed associations between PFOA exposure and self-reported high cholesterol, coronary artery disease, and hypertension using Cox proportional hazard models. (No probable link was found with the latter two health conditions.4) They used various exposure metrics in the models to account for different potential biological mechanisms, says Winquist. The models also controlled for potential confounders including birth year, because the patterns of exposure changed over time.
The serum predictions from the exposure model correlated quite well with the levels actually measured in the worker and community populations, which “bodes well for their accuracy,” says Steenland.
The exposure calculations did not factor in food or indoor dust, which are believed to be important routes through which people in the general population are exposed to PFOA, points out Christopher Lau, a researcher of developmental toxicology at the U.S. Environmental Protection Agency (EPA) National Health and Environmental Effects Research Laboratory. But he agrees that the research’s focus is justified by the high levels of PFOA released into the local environment by the DuPont plant over its decades of operation. He adds that the facility’s emissions recently decreased by more than 97% in concordance with a consent agreement with the EPA.10
One weakness of the study was that it only included community members alive in 2005–2006, so it may have excluded people who developed coronary artery disease and died before that point. Although the workers did not need to be alive by 2006 in order to be included in the study, it was difficult to find proxies (typically family members) who could provide information about deceased workers.4
Steenland and his colleagues on the C8 Science Panel stress that class action lawsuits involving environmental contaminants have only rarely produced data evaluating whether the exposure in question actually caused health effects. They hope this settlement, with its research requirements, sets a precedent for future settlements.11
References and Notes
1. C8 Science Panel [website]. C8 Science Panel (updated 28 November 2013). Available: http://www.c8sciencepanel.org/ [accessed 12 November 2014].
2. A “probable link” is defined under the terms of the settlement agreement to mean that, given the available scientific evidence, it is more likely than not that among class members a connection exists between PFOA exposure and a particular human disease. The finding of a probable link does not mean causality has been established.
3. C8 Probable Link Reports [website]. C8 Science Panel (updated 29 October 2012). Available: http://www.c8sciencepanel.org/prob_link.html [accessed 12 November 2014].
4. Winquist A, Steenland K. Modeled PFOA exposure and coronary artery disease, hypertension, and high cholesterol in community and worker cohorts. Environ Health Perspect 122(12):1299–1305 (2014); doi: 10.1289/ehp.1307943.
5. Kato K, et al. Trends in exposure to polyfluoroalkyl chemicals in the U.S. population: 1999–2008. Environ Sci Technol 45(19):8037–8045 (2011); doi: 10.1021/es1043613.
6. Winquist A, et al. Design, methods, and population for a study of PFOA health effects among highly exposed mid-Ohio valley community residents and workers. Environ Health Perspect 121(8):893–899 (2013); doi: 10.1289/ehp.1206450.
7. Shin HM, et al. Environmental fate and transport modeling for perfluorooctanoic acid emitted from the Washington Works facility in West Virginia. Environ Sci Technol 45(4):1435–1442 (2011); doi: 10.1021/es102769t.
8. Shin HM, et al. Retrospective exposure estimation and predicted versus observed serum perfluorooctanoic acid concentrations for participants in the C8 Health Project. Environ Health Perspect 119(12):1760–1765 (2011); doi: 10.1289/ehp.1103729.
9. Woskie SR, et al. Retrospective exposure assessment of perfluorooctanoic acid serum concentrations at a fluoropolymer manufacturing plant. Ann Occup Hyg 56(9):1025–1037 (2012); doi: 10.1093/annhyg/mes023.
10. EPA. Order on Consent Re: E.I. du Pont de Nemours and Company and Respondent Washington Works Facility. Docket Nos. SDWA-03-2007-0039-DS and SDWA-05-2007-0001. Philadelphia, PA and Chicago, IL:U.S. Environmental Protection Agency, Regions 3 and 5 (20 November 2006). Available: http://www.epa.gov/region03/enforcement/dupont_order.pdf [accessed 7 November 2014].
11. Steenland K, et al. Commentary: Class action lawsuits: can they advance epidemiologic research? Epidemiology 25(2):167–169 (2014); doi: 10.1097/EDE.0000000000000067.
Come visit with EHP’s Science Editor, Jane Schroeder, at the 2016 ISEE Meeting in Rome, Italy, from 1–4 September 2016. This is a great opportunity to meet a member of our team, and to learn more about the journal. A number of our Associate Editors will be in attendance as well. Jane is also co-hosting a half-day writing and publishing workshop on 4 September, following the conference.
EHP is pleased to present the abstracts from the 28th annual meeting of the International Society for Environmental Epidemiology (ISEE), held in Rome, Italy, 1–4 September 2016, and hosted by the Department of Epidemiology Lazio Regional Health Service, ASL Roma 1, and the Italian Epidemiological Association. The focus of this year’s conference is current and future challenges in exposure assessment, study design, and data analyses.
Featured Children’s Health
Birgit Claus Henn, Adrienne S. Ettinger, Marianne R. Hopkins, Rebecca Jim, Chitra Amarasiriwardena, David C. Christiani, Brent A. Coull, David C. Bellinger, and Robert O. Wright
Diane Gilbert-Diamond, Jennifer A. Emond, Emily R. Baker, Susan A. Korrick, and Margaret R. Karagas
Benjamin B. Green, Margaret R. Karagas, Tracy Punshon, Brian P. Jackson, David J. Robbins, E. Andres Houseman, and Carmen J. Marsit